MAP2K7 and cancer: EDI displayed an inhibitory effect on colon cancer cell proliferation (LS174T and HT29 cells) at least as strong as the effect of the MEK inhibitor PD98059 at concentrations previously shown to effectively reduce cancer cell proliferation7 (Fig. 5c and Supplementary Fig. 8).